SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-326074
Filing Date
2012-07-31
Accepted
2012-07-31 16:57:34
Documents
10
Period of Report
2012-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d387499d8k.htm 8-K 24294
2 UNDERWRITING AGREEMENT DATED AS OF JULY 26, 2012 d387499dex11.htm EX-1.1 171313
3 FORM OF SIXTH SUPPLEMENTAL INDENTURE d387499dex41.htm EX-4.1 248105
4 FORM OF 0.875% NOTES DUE 2017 d387499dex42.htm EX-4.2 44966
5 FORM OF 2.000% NOTES DUE 2022 d387499dex43.htm EX-4.3 44590
6 FORM OF 3.250% NOTES DUE 2042 d387499dex44.htm EX-4.4 44583
7 OPINION OF KIRKLAND & ELLIS LLP RELATING TO THE NOTES d387499dex51.htm EX-5.1 11263
8 $1,500,000,000 FIVE YEAR COMPETITIVE ADVANCE AND REVOLVING CREDIT FACILITY AGREE d387499dex101.htm EX-10.1 419019
9 GRAPHIC g387499ex5_1pg001.jpg GRAPHIC 6738
10 GRAPHIC g387499ex5_1pg002.jpg GRAPHIC 3360
  Complete submission text file 0001193125-12-326074.txt   1023686
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 12997503
SIC: 2834 Pharmaceutical Preparations